[Clinical analysis of 35 cases of vulvar intraepithelial neoplasia grade III].
Vulvar intraepithelial neoplasia, grade III, treated with photodynamic therapy: A case report.
Misdiagnosis of high-grade vulvar intraepithelial neoplasia (VIN III) as mild cervical intraepithelial neoplasia (CIN I) on Papanicolaou tests.
Vulvar intraepithelial neoplasia, grade III, treated with photodynamic therapy: A case report.
Chen T, Deng H, Fu Y, Zhao W, Li P, Peng J, Wang H, Hou S.
Photodiagnosis Photodyn Ther. 2023 Jun;42:103537. doi: 10.1016/j.pdpdt.2023.103537. Epub 2023 Mar 24.
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A; Broad Spectrum HPV Vaccine Study.
N Engl J Med. 2015 Feb 19;372(8):711-23. doi: 10.1056/NEJMoa1405044.
Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus.
van Beurden M, ten Kate FJ, Smits HL, Berkhout RJ, de Craen AJ, van der Vange N, Lammes FB, ter Schegget J.
Cancer. 1995 Jun 15;75(12):2879-84. doi: 10.1002/1097-0142(19950615)75:12<2879::aid-cncr2820751214>3.0.co;2-w.
Misdiagnosis of high-grade vulvar intraepithelial neoplasia (VIN III) as mild cervical intraepithelial neoplasia (CIN I) on Papanicolaou tests.
August CZ, Ganji M, Froula E.
Arch Pathol Lab Med. 2003 Jan;127(1):68-70. doi: 10.5858/2003-127-68-MOHGVI.
Impact of re-excision of residual adjacent vulvar intraepithelial neoplasia (VIN III) and histological tumour-free margin (hTFM) on survival in primary squamous cell carcinoma of vulva.
Gasimli K, Straussner M, Schmeil I, Karn T, Winkelmann R, Becker S, El-Balat A.
Arch Gynecol Obstet. 2018 Nov;298(5):945-950. doi: 10.1007/s00404-018-4887-1. Epub 2018 Sep 6.
GATA3 immunohistochemistry as a diagnostic adjunct for differentiated vulvar intraepithelial neoplasia: utility and limitations.
Zare SY, Fard EV, Fadare O.
Hum Pathol. 2023 Sep;139:55-64. doi: 10.1016/j.humpath.2023.07.005. Epub 2023 Jul 15.
Vulvar intraepithelial neoplasia III: a viral disease of undetermined progressive potential.
Hørding U, Junge J, Poulsen H, Lundvall F.
Gynecol Oncol. 1995 Feb;56(2):276-9. doi: 10.1006/gyno.1995.1046.
Cervical intraepithelial neoplasia III: long-term outcome after cold-knife conization with clear margins.
Reich O, Pickel H, Lahousen M, Tamussino K, Winter R.
Obstet Gynecol. 2001 Mar;97(3):428-30. doi: 10.1016/s0029-7844(00)01174-1.
Unveiling a Dermatological Rarity: The Enigma of Vulvar Intraepithelial Neoplasia Grade III (HSIL) and the Role of p53 in Its Development.
Brzeziński P, Feszak I, Ortiz BDM, Feszak S, Kawczak P, Bączek T.
Biomedicines. 2024 Aug 8;12(8):1799. doi: 10.3390/biomedicines12081799.
Expression of Ki-67 in vulvar carcinoma and vulvar intraepithelial neoplasia III: correlation with clinical prognostic factors.
Modesitt SC, Groben PA, Walton LA, Fowler WC Jr, Van Le L.
Gynecol Oncol. 2000 Jan;76(1):51-5. doi: 10.1006/gyno.1999.5655.
